BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16202016)

  • 1. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
    Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
    Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
    Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
    Hattori S; Yosioka K; Honda M; Ito H;
    Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing long-term survival in patients on chronic dialysis.
    Iseki K; Shinzato T; Nagura Y; Akiba T
    Clin Exp Nephrol; 2004 Jun; 8(2):89-97. PubMed ID: 15235924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of end-stage renal disease in last 10 years in Iran.
    Aghighi M; Mahdavi-Mazdeh M; Zamyadi M; Heidary Rouchi A; Rajolani H; Nourozi S
    Iran J Kidney Dis; 2009 Oct; 3(4):192-6. PubMed ID: 19841521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of incident dialysis patients in Tunisia between 1992 and 2001.
    Counil E; Cherni N; Kharrat M; Achour A; Trimech H
    Am J Kidney Dis; 2008 Mar; 51(3):463-70. PubMed ID: 18295062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an epidemic of HIV Infection in the US ESRD program?
    Eggers PW; Kimmel PL
    J Am Soc Nephrol; 2004 Sep; 15(9):2477-85. PubMed ID: 15339998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in end-stage renal disease and amount of protein intake in Japan.
    Motokawa M; Fukuda M; Muramatsu W; Sengo K; Kato N; Usami T; Yoshida A; Kimura G
    J Ren Nutr; 2007 Mar; 17(2):118-25. PubMed ID: 17321951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger.
    Iseki K; Wakugami K; Maehara A; Tozawa M; Muratani H; Fukiyama K
    Am J Kidney Dis; 2001 Dec; 38(6):1235-9. PubMed ID: 11728955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
    Yang WC; Hwang SJ;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3977-82. PubMed ID: 18628366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
    Gilbertson DT; Liu J; Xue JL; Louis TA; Solid CA; Ebben JP; Collins AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3736-41. PubMed ID: 16267160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing body mass index and obesity in the incident ESRD population.
    Kramer HJ; Saranathan A; Luke A; Durazo-Arvizu RA; Guichan C; Hou S; Cooper R
    J Am Soc Nephrol; 2006 May; 17(5):1453-9. PubMed ID: 16597682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of end-stage renal disease and body mass index in a screened cohort.
    Iseki K; Ikemiya Y; Fukiyama K
    Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal Epidemiology and Information Network: 2007 annual report ].
    Couchoud C; Lassalle M; Stengel B; Jacquelinet C
    Nephrol Ther; 2009 Jun; 5 Suppl 1():S3-144. PubMed ID: 19524212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of dialysis: special issues in women.
    Gipson D; Katz LA; Stehman-Breen C
    Semin Nephrol; 1999 Mar; 19(2):140-7. PubMed ID: 10192246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.